Wall Street is positive on Companhia Brasileira de Distribuicao SA (CBD). On average, analysts give CBD a Buy rating. The average price target is $5.5, which means analysts expect the stock to rise by 35.80% over the next twelve months.
That average ranking earns CBD an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating CBD a Buy today. Find out what this means to you and get the rest of the rankings on CBD!
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Companhia Brasileira de Distribuicao SA Stock Today?
Companhia Brasileira de Distribuicao SA (CBD) stock is lower by -0.98% while the S&P 500 is up 0.72% as of 2:58 PM on Thursday, Jan 26. CBD is down -$0.04 from the previous closing price of $4.09 on volume of 586,036 shares. Over the past year the S&P 500 has fallen -7.01% while CBD is up 2.53%. CBD earned $1.25 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.24.
Click Here to get the full Stock Report for Companhia Brasileira de Distribuicao SA stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter